SCHEMBL4972811

SCHEMBL4972811

CC(NC(=O)OC(C)(C)C)C(N)Oc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CTSK P43235 5/20 0.43
▸ CTSS P25774 4/20 0.43
▸ ATM Q13315 1/20 0.43
▸ MMP13 P45452 1/20 0.42
▸ CTSL P07711 1/20 0.41
▸ CTSB P07858 1/20 0.41
▸ GABRB1 P18505 1/20 0.41
▸ GABRB2 P47870 1/20 0.41
▸ PPARA Q07869 2/20 0.41
▸ PPARG P37231 1/20 0.41
▸ ACE P12821 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19357527 0.84 CTSK (0.44) CTSKCTSSATMMMP13CTSL
SCHEMBL23691867 0.84 CTSK (0.44) CTSKCTSSATMMMP13CTSL
SCHEMBL14923545 0.79 CTSK (0.51) CTSKCTSSATMCTSLCTSB
SCHEMBL15632507 0.79 CTSK (0.51) CTSKCTSSATMCTSLCTSB
SCHEMBL7400537 0.79 CTSK (0.51) CTSKCTSSATMCTSLCTSB
SCHEMBL15632169 0.79 CTSK (0.51) CTSKCTSSATMCTSLCTSB
SCHEMBL25076073 0.77 SLC1A3 (0.44) CTSKCTSSATMMMP13CTSL
SCHEMBL9404368 0.77 CTSS (0.45) CTSKCTSSATMMMP13CTSL
SCHEMBL8909055 0.77 CTSS (0.45) CTSKCTSSATMMMP13CTSL
SCHEMBL15081404 0.76 ATM (0.57) CTSKCTSSATMCTSLCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966139-A1 ASPARTIC PROTEASE INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2008-09-10 — — EP disclosed
WO-2007070201-A1 ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2007-06-21 — — WO disclosed
Send feedback